Rituximab으로 치료한 자가면역 질환 2 례

• 영문명: Experience of Rituximab Treatment in Two Patients with Autoimmune Disease
• 발행기관: 조선대학교 의학연구원
• 저자명: 장광표(Kwang-Pyo Jang) 강지은(ji-Eun Kang) 박치영(Chi-Young Park)
• 간행물 정보: 『The Medical Journal of Chosun University』제33권 제3호, 92~94쪽, 전체 3쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2008.09.30

영문 초록

Rituximab， a monoclonal anti-CD20 chimeric antibody, has successfully been used to treat B cell lymphoma, and has recently been shown to be effective for the treatment of autoimm니ne diseases such as idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia. We report the experience of rituximab treatment in two patients with autoimmue disease. The first case is 68-year-old female patient with autoimmue thrombocytopenic purpura，and the second case is 26-years-old female patient with autoimmue hemolytic anemia. Therapy with rituximab appears to be promising in patients with steroid refractory autoimmune disease.

목차

서 론

증 례1

증 례 2

치료 및 경과

고 찰